BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19630744)

  • 1. Review of topiramate: an antiepileptic for the treatment of alcohol dependence.
    Kenna GA; Lomastro TL; Schiesl A; Leggio L; Swift RM
    Curr Drug Abuse Rev; 2009 May; 2(2):135-42. PubMed ID: 19630744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate in Alcohol Use Disorders: Review and Update.
    Guglielmo R; Martinotti G; Quatrale M; Ioime L; Kadilli I; Di Nicola M; Janiri L
    CNS Drugs; 2015 May; 29(5):383-95. PubMed ID: 25899459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.
    Liang J; Olsen RW
    Acta Pharmacol Sin; 2014 Aug; 35(8):981-93. PubMed ID: 25066321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of topiramate and other anticonvulsants in the treatment of alcohol dependence: a clinical review.
    De Sousa A
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):45-9. PubMed ID: 20201814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.
    Ait-Daoud N; Malcolm RJ; Johnson BA
    Addict Behav; 2006 Sep; 31(9):1628-49. PubMed ID: 16472931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence.
    Johnson BA
    Expert Opin Pharmacother; 2004 Sep; 5(9):1943-55. PubMed ID: 15330732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state of pharmacotherapy for the treatment of alcohol dependence.
    Garbutt JC
    J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of alcohol use disorders: seventy-five years of progress.
    Zindel LR; Kranzler HR
    J Stud Alcohol Drugs Suppl; 2014; 75 Suppl 17(Suppl 17):79-88. PubMed ID: 24565314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological review of alcoholic dependence treatment].
    Oural L; Paris MV; Sullivan O; Polach M; Pavlovsky F; Capece J
    Vertex; 2008; 19(77):512-21. PubMed ID: 18443665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
    Johnson BA
    Biochem Pharmacol; 2008 Jan; 75(1):34-56. PubMed ID: 17880925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of alcohol dependence: a systematic review.
    Miller PM; Book SW; Stewart SH
    Int J Psychiatry Med; 2011; 42(3):227-66. PubMed ID: 22439295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pharmacological approaches for the treatment of alcoholism.
    Soyka M; Roesner S
    Expert Opin Pharmacother; 2006 Dec; 7(17):2341-53. PubMed ID: 17109610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.
    Falk D; Wang XQ; Liu L; Fertig J; Mattson M; Ryan M; Johnson B; Stout R; Litten RZ
    Alcohol Clin Exp Res; 2010 Dec; 34(12):2022-34. PubMed ID: 20659066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.
    Goh ET; Morgan MY
    Aliment Pharmacol Ther; 2017 Apr; 45(7):865-882. PubMed ID: 28220511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of alcohol dependence.
    Hanwella R; de Silva V
    Ceylon Med J; 2009 Jun; 54(2):63-5. PubMed ID: 19670554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2.
    Kenna GA; McGeary JE; Swift RM
    Am J Health Syst Pharm; 2004 Nov; 61(22):2380-8. PubMed ID: 15581261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
    Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.